TRCT
ACTU

Tower Research Capital (TRC)’s Actuate Therapeutics, Inc. Common stock ACTU Stock Holding History

Tower Research Capital (TRC)’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$79 Sell
13
-2,542
-99% -$15.4K ﹤0.01% 5165
2025
Q1 		$17.3K Buy
+2,555
New +$17.3K ﹤0.01% 3111
2024
Q4 		– Sell
-297
Closed -$2.21K – 6084
2024
Q3 		$2.21K Buy
+297
New +$2.21K ﹤0.01% 5029